Summary.-Serum concentrations of oestradiol-173 were measured daily throughout one menstrual cycle in 32 normal women, 31 women with benign disease of the breast and 10 with cancer of the breast. The concentrations were found to differ significantly from normal in women with cysts and to a lesser extent in those with cancer of the breast. In 25 normal post-menopausal and in 27 post-menopausal women with cancer repeated assays disclosed consistently low levels of oestradiol-17/f.
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IT SEEMS CLEAR that there is a relationship between ovarian function and the development of both benign and malignant disease of the breast but the nature of this relationship has not yet been defined (Hayward, 1972; MacMahon and Cole, 1972;  MacMahon, Cole and Brown, 1973) .
The most common benign condition has been given a variety of names but is known most often as fibroadenosis (Semb, 1928; Atkins, 1947) . It is characterized clinically by painful, lumpy breasts and histologically by fibrosis and hyperplasia of the epithelial tissue. Symptoms appear initially during reproductive life (25-45 years) and disappear at the menopause (Taylor, 1936; Lewison, 1971) . Typically, they are related to the stage of the menstrual cycle so that breasts become painful before menstruation and lumps which may appear during the luteal phase of the cycle regress or disappear after menstruation. Single and multiple cysts of the breast are also common and may show cyclical changes similar to those in fibroadenosis. They are considered by many to be a manifestation of the same condition. The cyclical nature of the clinical features and their limitation to the period of reproductive life suggest strongly an endocrine cause; similar changes including cysts may be produced in laboratory animals by prolonged administration of oestrogens (Goormaghtigh and Amerlinck, 1930; Burrows, 1935) .
Several studies of urinary oestrogen excretion in patients with cancer of the breast have been reported but the results are conflicting and confusing (Brown, 1958; Bacigalupo and Schubert, 1960; Trvine et al., 1961; Jull, Shucksmith and Bonser, 1963; Nissen-Meyer and Sanner, 1963; Perrson and Risholm, 1964; Marmorston et al., 1965; Lemon et al., 1966; Schweppe, Jungman and Lewin, 1967; Arguelles et al., 1973 (Cameron and Jones, 1972) . In a previous study (England et al., 1974) (England et al., 1974) . The addition of two more since this publication has not None of the subjects studied had a history of gynaecological disease or was taking any hormonal preparation.
Collection of blood sanmples.-Peripheral venous blood (approximately 10 ml) was collected daily between 9 a.m. and 12 noon. The blood was allowed to clot, centrifuged and the serum removed and stored at -20°C.
Measurement of serum oestradiol-173.-Radioimmunoassay of oestradiol-17/3 was carried out by the method described previously (Cameron and Jones, 1972; England et al., 1974) . By counting the radioactive supernatant sample (0.5 ml) in 10 ml of a 1 : 1 dilution with Scintillator Grade Xylene of PCS-Liquid scintillation cocktail (Hopkins and Williams, Chadw%Aell Heath, Essex) counting efficiency was rasied to approximately 38%o.
Expression of results.-The lengths of the cycles varied greatly, so that a reference point other than the first day of the cycle was needed for comparative purposes. The day of the mid-cycle peak of oestradiol-17/3 was used as the reference poinit and designated as Day 0. Preceding days wN-ere given negative numbers and the days following positive numbers. Days -11 to -4 w%iere referred to as the follicular phase and Day + 4 to + 12 as the luteal phase. Groups were compared by the statistical method ofpaired comparison.
RESULTS
A. Benign disease 1. In women with painful lumpy breasts the results were essentially normal and the variation in results was less than that in normal women. When individual profiles were compared with the mean profile for normal women the range of differences was as follows:
(a) 20-29 age group.-Follicular phase -14-6 to + 9 2 pg/ml (normal range 17-2 to +1 3 1.). Luteal phase -1 0 to + 1 4 6 pg/ml (normal range 29 6 to +32 7).
(b) 30-39 age group.-Follicular phase -11 4 to +51*1 pg/ml (normal range -22*6 to +22 2). Luteal phase 29-0 to +37 3 pg/ml (normal range 51 6 to +43 6). luteal phase of the cycle was significantly higher than that of normal women. Of the 5 women in the 30-39 year age group, 3 had significantly higher values than normal and only one had a lower value. The overall mean difference was 18 0 + 5 8 (s.e. mean) pg/ml (P < 0.01) (Fig. 1) . The overall mean difference of the women in the 40-49 year age group was of the cycle the mean concentrationi of oestradiol-17/? in patients with cancer of the breast was slightly but significantly greater than that in normal women (Fig. 3) . In the follicular phase (Day -11 to Day 4), using the method of paired comparison, the overall mean difference was 6 1 + 2*3 (s.e. mean) pg/ml (P < 0.05) and in the luteal phase (Day + 4 to Fie. 3. MIean concentration of oestradiol-17fi in normal pre-menopausal women aged 40-49 vears and in women with cancer of the breast. Paired comparisons in follicular phase P < 005 an(d in luteal phase P < 0'05. (Bonser, Dossett and Jull, 1961) . In those with cysts, the concentrations were significantly high during the luteal phase of the cycle and 2 women in the 40-49 age group had exceptionally high values. Cystic disease may well be a separate entity with an aetiology different from that of the condition usually described as fibroadenosis. A critical histological study of nonmalignant conditions of the breast is needed so that we can define our terms more accurately.
The results in pre-menopausal women with cancer of the breast varied greatly and were difficult to interpret. In both follicular and luteal phases the mean concentrations were significantly greater than those in normal women, but this finding may give a misleading impression. The striking feature was the marked variation in either direction from the mean normal profile. Greater numbers will need to be studied before the abnormality can be defined clearly. Several studies have indicated a relationship between cancer of the breast and previous benign disease (Warren, 1940; Logie, 1942; Foote and Stewart, 1945; Lewison and Lyons, 1953; Hodge, Surver and Aponte, 1959; Humphrey and Swerdlow, 1962) , in particular cysts (Haagensen, 1971) . Our data suggest there may be a similar endocrine abnormality in both cancer and benign cystic disease.
The endocrine background to cancer of the breast is unlikely to be explained by measurement of a single hormone. Oestriol and progesterone, which are considered by some to exert a protective effect (Lemon et al., 1966; MacMahon et al., 1973) , require detailed study.
In post-menopausal women, with or without cancer of the breast, the concentrations of oestradiol-17,8 were extremely low and at the lower limit of the sensitivity of our assay. It might be more rewarding to study oestrone, the concentrations of which are relatively high in post-menopausal women (Rader et al., 1973 
